X Chromosome Silenced in Some Cancers in Males

A study finds that XIST, the gene that shuts down one X chromosome in people who have two, is linked to cancer in males.

Written byNatalia Mesa, PhD
| 3 min read
3D Illustration of X shaped chromosomes in blue
Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Humans only need one active X chromosome, which means that people with two must shut one down to avoid doubling up on its protein products. The gene tasked with inactivating one X, called XIST, codes for a long noncoding RNA that coats and epigenetically silences the extra X chromosome early in the development of people with two X chromosomes. XIST has previously been linked to cancer in females, as well as to testicular cancer. Now, in a study published November 9 in Cell Systems, researchers have found XIST activity in cancers in various somatic tissues of males, too.

Irregular XIST activity has been linked to testicular cancers, which arise from male germ cells. But in the new study, the researchers found high levels of XIST RNA in male somatic cells sampled from cancerous tissues. While the study doesn’t show a causal link been XIST expression and male cancers, it finds ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A black and white headshot

    As she was completing her graduate thesis on the neuroscience of vision, Natalia found that she loved to talk to other people about how science impacts them. This passion led Natalia to take up writing and science communication, and she has contributed to outlets including Scientific American and the Broad Institute. Natalia completed her PhD in neuroscience at the University of Washington and graduated from Cornell University with a bachelor’s degree in biological sciences. She was previously an intern at The Scientist, and currently freelances from her home in Seattle. 

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies